Please see the advert below for a new post at CRCTU:
UNIVERSITY OF BIRMINGHAM
School of Cancer Sciences
Cancer Research UK Clinical Trials Unit
Biostatistician
Fixed term for 12 months in the first instance
The Cancer Research UK Clinical Trials Unit (CRCTU) at the University of
Birmingham has a new core-funded position available for an experienced
Biostatistician to work primarily on trials of treatments for children’s cancer.
The Children’s Cancer and Leukaemia Group (CCLG) has a large and varied
portfolio of trials across a range of paediatric tumours, with several new trials
being developed. There are particular challenges related to trials in rare
diseases and the appointee will be involved at all stages of the trial process,
from design (including assessment of the current evidence base through meta-
analysis of previous trials) through to analysis and reporting.
This is an exciting opportunity to join one of the largest of the National Cancer
Research Institute Accredited Trials Units in the UK. The Unit is part of the
School of Cancer Sciences which includes the first of Cancer Research UK's
national Cancer Centres. The Unit has an extensive portfolio of phase II and
III clinical trials in a wide range of cancer disease sites and has one of the
most active early drug development teams in the country. The Unit hosts a
team funded by Leukaemia Research supporting phase II trial development in
haematology, including paediatrics, on a national level.
Biostatisticians play a central role in the CRCTU, actively liaising with clinical
investigators and other trial personnel, contributing to the design and conduct
of clinical trials, being responsible for interim and final analysis of trial data and
having a key role in the presentation and publication of results. As academic
members of the University, Biostatisticians contribute to teaching at under-
graduate and post-graduate level. In addition the Unit is actively involved in
researching statistical methodology related to clinical trials and associated
translational research and is closely affiliated with the new Midland Hub for
Trials Methodology Research funded by the Medical Research Council.
Opportunities will exist for the appointee to pursue their own research,
especially on trial methodology for rare diseases. Registration for a post-
graduate qualification may be possible.
For informal enquiries please contact Professor Keith Wheatley:
[log in to unmask] or 0121 415 9119.
Starting salary £27,183 a year in the range of £27,183 to £35,469 a year
(potential progression on performance once in post to £37,651)
Closing date: 7 October 2009
Reference: 46620
To download the details and submit an electronic application online visit:
www.hr.bham.ac.uk/jobs alternatively information can be obtained from 0121
415 9000.
A University of Fairness and Diversity.
|